AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Fife, BT Kennedy, KJ Paniagua, MC Lukacs, NW Kunkel, SL Luster, AD Karpus, WJ
Citation: Bt. Fife et al., CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4(+)T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis, J IMMUNOL, 166(12), 2001, pp. 7617-7624

Authors: Fife, BT Huffnagle, GB Kuziel, WA Karpus, WJ
Citation: Bt. Fife et al., CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis, J EXP MED, 192(6), 2000, pp. 899-905

Authors: Matthews, E Yang, T Janulis, L Goodwin, S Kundu, SD Karpus, WJ Lee, C
Citation: E. Matthews et al., Down-regulation of TGF-beta 1 production restores immunogenicity in prostate cancer cells, BR J CANC, 83(4), 2000, pp. 519-525

Authors: Hoffman, LM Fife, BT Begolka, WS Miller, SD Karpus, WJ
Citation: Lm. Hoffman et al., Central nervous system chemokine expression during Theiler's virus-induceddemyelinating disease, J NEUROVIRO, 5(6), 1999, pp. 635-642

Authors: Karpus, WJ
Citation: Wj. Karpus, Chemokine regulation of inflammatory-mediated nervous system diseases, J NEUROVIRO, 5(1), 1999, pp. 1-2

Authors: Kennedy, KJ Karpus, WJ
Citation: Kj. Kennedy et Wj. Karpus, Role of chemokines in the regulation of Th1/Th2 and autoimmune encephalomyelitis, J CLIN IMM, 19(5), 1999, pp. 273-279

Authors: Hoffman, LM Karpus, WJ
Citation: Lm. Hoffman et Wj. Karpus, Chemokine regulation of CNS T-cell infiltration in experimental autoimmuneencephalomyelitis, RES IMMUNOL, 149(9), 1998, pp. 790-794

Authors: Willenborg, DO Racke, MK Lovett-Racke, AE Hoffman, LM Karpus, WJ Owens, T
Citation: Do. Willenborg et al., Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental encephalomyelitis - Discussion, RES IMMUNOL, 149(9), 1998, pp. 843-844

Authors: Segal, BM Willenborg, DO Racke, MK Lovett-Racke, AE Hoffman, LM Karpus, WJ Begolka, WS Miller, SD
Citation: Bm. Segal et al., Immune cell entry to the CNS - a focus for immunoregulation of EAE - Discussion, RES IMMUNOL, 149(9), 1998, pp. 844-846

Authors: Begolka, WS Miller, SD Hoffman, LM Karpus, WJ Owens, T Racke, MK
Citation: Ws. Begolka et al., The comeback of the elusive "suppressor" cell: an update on the regulatorynetwork in EAE - Discussion, RES IMMUNOL, 149(9), 1998, pp. 850-851

Authors: Hoffman, LM Karpus, WJ Owens, T Begolka, WS Miller, D
Citation: Lm. Hoffman et al., Bystander suppression in experimental autoimmune encephalomyelitis: where and how does it occur? Discussion, RES IMMUNOL, 149(9), 1998, pp. 851-852

Authors: Segal, BM Owens, T Karpus, WJ Begolka, WS Miller, SD
Citation: Bm. Segal et al., TCR peptide-reactive T cells and peripheral tolerance to myelin basic protein - Discussion, RES IMMUNOL, 149(9), 1998, pp. 852-854

Authors: Kennedy, KJ Strieter, RM Kunkel, SL Lukacs, NW Karpus, WJ
Citation: Kj. Kennedy et al., Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1 alpha and monocyte chemotactic protein-1, J NEUROIMM, 92(1-2), 1998, pp. 98-108
Risultati: 1-13 |